Clincosm LogoSign in Get a demo

Flat OGTT (Oral Glucose Tolerance Test) During Pregnancy

Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04515823
Collaborator
(none)
2,085
Enrollment
1
Location
3.2
Actual Duration (Months)
654.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of the study is to examine the relationship between "flat" sugar curve on OGTT-glucose tolerance test during pregnancy, neonatal birthweight and other perinatal outcomes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A retrospective cohort analysis of all women delivered in one university affiliated medical center between January 1st 2018 and December 31th 2019 with documented 100 grams OGTT results.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2085 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    The Flat OGTT During Pregnancy -Prevalence and Risk for Adverse Outcomes
    Actual Study Start Date :
    Apr 26, 2020
    Actual Primary Completion Date :
    Aug 1, 2020
    Actual Study Completion Date :
    Aug 1, 2020

    Outcome Measures

    Primary Outcome Measures

    1. To evaluate the characteristics and perinatal outcomes of parturients with a flat glucose curve on 100 grams oral glucose tolerance test (OGTT). [10 months]

      A flat OGTT curve occurs in a younger, leaner population. Although flat OGTT can possibly reflect some degree of hyperinsulinemia, it is generally not associated with adverse maternal or neonatal outcomes.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Performing the OGTT test during the pregnancy
    Exclusion Criteria:
    • lack of documentation or Non-performance of OGTT test during the pregnancy.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Obstetrics and Gynecology, Hillel-Yaffe Medical Center Hadera Israel 38100

    Sponsors and Collaborators

    • Hillel Yaffe Medical Center

    Investigators

    • Principal Investigator: Rinat Gabbay-Benziv, M.D, Hillel Yaffe Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hillel Yaffe Medical Center
    ClinicalTrials.gov Identifier:
    NCT04515823
    Other Study ID Numbers:
    • 0052-20-HYMC
    First Posted:
    Aug 17, 2020
    Last Update Posted:
    Aug 19, 2020
    Last Verified:
    Aug 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 19, 2020